Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Alankrita Taneja's interest lie in hematological malignancies including lymphoma and multiple myeloma, with a special interest in cellular therapies. She also did a course in global and urban health equity while in residency and she is interested in health disparities and equitable care.
For more information, visit https://www.roswellpark.org/alankrita-taneja
एलजीबीटीक्यू समुदाय के लिए हेमेटोलॉजिकल विचार - Hematological Considerations for LGBTQ+ Community Presented in Hindi
AlexandraGBeneke
Dr. Alankrita Taneja discusses issues surrounding the transgender community in India, including possible side effects of gender-affirming therapy.
Image
Dr. Alankrita Taneja discusses issues surrounding the transgender community in India, including possible side effects of gender-affirming therapy.
डॉ। अलंकृता तनेजा भारत में ट्रांसजेंडर समुदाय से जुड़ी मुद्दों पर चर्चा करती हैं, जिसमें जेंडर अफर्मिंग थेरेपी के संभव दुष्प्रभाव भी शामिल हैं।
To watch the complete HPV Program series, visit the full video playlist here.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...